A Strategy for Developing New Treatment Paradigms for Neuropsychiatric and Neurocognitive Symptoms in Alzheimer’s Disease

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2013.00047
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer’s Disease

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2020English

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients With Alzheimer’s Disease

Canadian Geriatrics Journal
GerontologyGeriatrics
2013English

Advances in Developing Novel Therapeutic Strategies for Alzheimer’s Disease

Molecular Neurodegeneration
Molecular NeuroscienceNeurologyMolecular BiologyCellular
2018English

Associations of Cerebrovascular Metabolism Genotypes With Neuropsychiatric Symptoms and Age at Onset of Alzheimer’s Disease Dementia

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2017English

Neuropsychiatric Symptoms in a European Huntington's Disease Cohort (REGISTRY)

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2014English

A Template for New Drugs Against Alzheimer’s Disease

Cell
BiochemistryGeneticsMolecular Biology
2013English

Neuropsychiatric Symptoms in Untreated Parkinson’s Disease

Neuropsychiatric Disease and Treatment
2017English

Drug Repurposing Is a New Opportunity for Developing Drugs Against Neuropsychiatric Disorders

Schizophrenia Research and Treatment
PsychiatryMental HealthNeurology
2016English

Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders
PsychiatryGerontologyGeriatricsMental HealthCognitive Neuroscience
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy